Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in …
P Toniati, S Piva, M Cattalini, E Garrafa, F Regola… - Autoimmunity …, 2020 - Elsevier
A hyperinflammatory syndrome (HIS) may cause a life-threatening acute respiratory distress
syndrome (ARDS) in patients with COVID-19 pneumonia. A prospective series of 100 …
syndrome (ARDS) in patients with COVID-19 pneumonia. A prospective series of 100 …
An update on current therapeutic drugs treating COVID-19
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes
J Van Paassen, JS Vos, EM Hoekstra, KMI Neumann… - Critical Care, 2020 - Springer
Background In the current SARS-CoV-2 pandemic, there has been worldwide debate on the
use of corticosteroids in COVID-19. In the recent RECOVERY trial, evaluating the effect of …
use of corticosteroids in COVID-19. In the recent RECOVERY trial, evaluating the effect of …
Pharmaco-immunomodulatory therapy in COVID-19
The severe acute respiratory syndrome coronavirus 2 associated coronavirus disease 2019
(COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory …
(COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory …
Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis
D Chaudhuri, K Sasaki, A Karkar, S Sharif… - Intensive care …, 2021 - Springer
Purpose Corticosteroids are now recommended for patients with severe COVID-19 including
those with COVID-related ARDS. This has generated renewed interest regarding whether …
those with COVID-related ARDS. This has generated renewed interest regarding whether …
Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia
MA Pinzón, S Ortiz, H Holguín, JF Betancur… - PloS one, 2021 - journals.plos.org
Background There is no effective therapy for the severe acute respiratory syndrome by
coronavirus 2 (SARS-CoV2) responsible for the Coronavirus disease 2019 (Covid-19). To …
coronavirus 2 (SARS-CoV2) responsible for the Coronavirus disease 2019 (Covid-19). To …
Dexamethasone for the treatment of coronavirus disease (COVID-19): a review
MH Ahmed, A Hassan - SN comprehensive clinical medicine, 2020 - Springer
Abstract The World Health Organization (WHO) declared COVID-19 (novel coronavirus) as a
global pandemic in the middle of March 2020, after the disease spread to more than 150 …
global pandemic in the middle of March 2020, after the disease spread to more than 150 …
[HTML][HTML] Pharmaceutical compounds used in the COVID-19 pandemic: A review of their presence in water and treatment techniques for their elimination
CA Morales-Paredes, JM Rodríguez-Díaz… - Science of the Total …, 2022 - Elsevier
During the COVID-19 pandemic, high consumption of antivirals, antibiotics, antiparasitics,
antiprotozoals, and glucocorticoids used in the treatment of this virus has been reported …
antiprotozoals, and glucocorticoids used in the treatment of this virus has been reported …
ICU outcomes and survival in patients with severe COVID-19 in the largest health care system in central Florida
E Oliveira, A Parikh, A Lopez-Ruiz, M Carrilo… - PloS one, 2021 - journals.plos.org
Background Observational studies have consistently described poor clinical outcomes and
increased ICU mortality in patients with severe coronavirus disease 2019 (COVID-19) who …
increased ICU mortality in patients with severe coronavirus disease 2019 (COVID-19) who …
Pulmonary infections complicating ARDS
Pulmonary infection is one of the main complications occurring in patients suffering from
acute respiratory distress syndrome (ARDS). Besides traditional risk factors, dysregulation of …
acute respiratory distress syndrome (ARDS). Besides traditional risk factors, dysregulation of …